Novus International, Inc., announced its acquisition of enzyme company BioResource International, Inc., also known as BRI, in March. Under the terms of the agreement, NOVUS became the owner of all BRI’s products and intellectual property and takes control of the company’s facilities.
In making the announcement, the leader in intelligent nutrition cited supply chain optimization, product diversification, and innovation as reasons behind the deal.

In today’s episode of the Feedstuffs in Focus, we talk with NOVUS President and CEO Dan Meagher about the recent acquisition of BRI and his company’s plans.